- Home
- Publications
- Publication Search
- Publication Details
Title
Drug interactions with new hepatitis C oral drugs
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 11, Issue 3, Pages 333-341
Publisher
Informa Healthcare
Online
2015-01-02
DOI
10.1517/17425255.2015.998997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beyond sofosbuvir: What opportunity exists for a better nucleoside/nucleotide to treat hepatitis C?
- (2014) Michael J. Sofia ANTIVIRAL RESEARCH
- Towards hepatitis C eradication from the HIV-infected population
- (2014) Pablo Barreiro et al. ANTIVIRAL RESEARCH
- ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2014) Ivan Gentile et al. CURRENT MEDICINAL CHEMISTRY
- Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
- (2014) Adriano M. Pellicelli et al. DIGESTIVE AND LIVER DISEASE
- Daclatasvir + Asunaprevir: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C
- (2014) Guido Stirnimann EXPERT OPINION ON PHARMACOTHERAPY
- Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
- (2014) Ivan Gentile et al. Expert Review of Anti-Infective Therapy
- Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
- (2014) Ivan Gentile et al. Expert Review of Anti-Infective Therapy
- New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
- (2014) Jean–Michel Pawlotsky GASTROENTEROLOGY
- HCV cirrhosis at the edge of decompensation: Will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?
- (2014) Tarik Asselah et al. JOURNAL OF HEPATOLOGY
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2014
- (2014) JOURNAL OF HEPATOLOGY
- Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection
- (2013) Drosos E. Karageorgopoulos et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The importance of drug–drug interactions in the DAA era
- (2013) David Back et al. DIGESTIVE AND LIVER DISEASE
- Emerging treatments for hepatitis C
- (2013) Robert Flisiak et al. EXPERT OPINION ON EMERGING DRUGS
- Simeprevir for the treatment of chronic hepatitis C
- (2013) David M You et al. EXPERT OPINION ON PHARMACOTHERAPY
- Hepatitis C therapy with HCV NS5B polymerase inhibitors
- (2013) Vincent Soriano et al. EXPERT OPINION ON PHARMACOTHERAPY
- Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting
- (2013) Sarah Tischer et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Focus
- (2013) Daniel Shouval JOURNAL OF HEPATOLOGY
- Drug–drug interactions during antiviral therapy for chronic hepatitis C
- (2013) Jennifer J. Kiser et al. Nature Reviews Gastroenterology & Hepatology
- Pharmacokinetics of new oral hepatitis C antiviral drugs
- (2012) Eugenia Vispo et al. Expert Opinion on Drug Metabolism & Toxicology
- Current prospects for interferon-free treatment of hepatitis C in 2012
- (2012) Catherine AM Stedman JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Clinical management of drug–drug interactions in HCV therapy: Challenges and solutions
- (2012) David Burger et al. JOURNAL OF HEPATOLOGY
- Perspectives and challenges of interferon-free therapy for chronic hepatitis C
- (2012) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients
- (2011) Vincent Soriano et al. AIDS
- Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV–HCV-coinfected patients
- (2011) Ana Treviño et al. ANTIVIRAL THERAPY
- Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients
- (2011) Inmaculada Jiménez-Nácher et al. Expert Opinion on Drug Metabolism & Toxicology
- Directly acting antivirals for hepatitis C and antiretrovirals
- (2011) Kay Seden et al. Current Opinion in HIV and AIDS
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
- (2009) Pablo Labarga et al. AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More